Accelovance Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Accelovance Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010839
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Accelovance Inc (Accelovance) is a contract research organization that offers CRO services, patient recruitment, and clinical call center services in various therapeutic areas including oncology, immunization/infectious disease, CNS, renal care and others. The organization’s CRO services include protocol development, project management, clinical trial monitoring, biostatistics, medical writing, data management, and pharmacovigilance services. Accelovance’s clinical call center services comprise surveillance programs, patient-reported outcomes, observational studies, site support services, recruitment, patient market research, and other services. Accelovance provides CRO services to pharmaceutical companies, CROs, biotechs and academic institutions. The company operates in the US, the UK, Israel, Russia, and China. Accelovance is headquartered in Rockville, Maryland, the US.

Accelovance Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Accelovance Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Accelovance Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Accelovance Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Accelovance Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Accelovance Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Accelovance Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Immunicum Enters into Agreement with Accelovance and Midwest Melanoma Partnership 10
Accelovance Enters into Partnership with FHI 360 11
Accelovance and Midwest Melanoma Partnership Enters into Agreement 12
Acquisition 13
Accelovance Acquires CRO Business of THERAMetrics 13
Accelovance Acquires Clinquest and Clinquest Services from Clinquest Group 14
Accelovance Acquires Altair Clinical 15
Accelovance Acquires Radiant Development, Contract Research Organization 16
Accelovance Inc – Key Competitors 17
Accelovance Inc – Key Employees 18
Accelovance Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Accelovance Inc, Pharmaceuticals & Healthcare, Key Facts 2
Accelovance Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Accelovance Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Accelovance Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Accelovance Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Accelovance Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Immunicum Enters into Agreement with Accelovance and Midwest Melanoma Partnership 10
Accelovance Enters into Partnership with FHI 360 11
Accelovance and Midwest Melanoma Partnership Enters into Agreement 12
Accelovance Acquires CRO Business of THERAMetrics 13
Accelovance Acquires Clinquest and Clinquest Services from Clinquest Group 14
Accelovance Acquires Altair Clinical 15
Accelovance Acquires Radiant Development, Contract Research Organization 16
Accelovance Inc, Key Competitors 17
Accelovance Inc, Key Employees 18
Accelovance Inc, Other Locations 19
Accelovance Inc, Subsidiaries 20

★海外企業調査レポート[Accelovance Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Verax Biomedical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Verax Biomedical Inc (Verax) is a developer of rapid tests for the detection of bacterial contaminants in tissues for transplantation, blood components, and cellular therapies. The company’s products include platelet pgd test, red cell pgd test and cell therapy PGD test. It uses the PGD tech …
  • GOJO Industries Inc:企業の戦略・SWOT・財務情報
    GOJO Industries Inc - Strategy, SWOT and Corporate Finance Report Summary GOJO Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • G4S plc:企業のM&A・事業提携・投資動向
    G4S plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's G4S plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Eutelsat Communications Group:企業の戦略・SWOT・財務分析
    Eutelsat Communications Group - Strategy, SWOT and Corporate Finance Report Summary Eutelsat Communications Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sanford Burnham Prebys Medical Discovery Institute-製薬・医療分野:企業M&A・提携分析
    Summary Sanford Burnham Prebys Medical Discovery Institute (Sanford Burnham) is a non-profit public benefit institute that offers medical research services. The institute offers research programs in the field of tumor initiation and maintenance, cancer metabolism and signaling networks, tumor microe …
  • Laredo Petroleum Inc (LPI):企業の財務・戦略的SWOT分析
    Laredo Petroleum Inc (LPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Bryce Corporation
    Bryce Corporation - Strategy, SWOT and Corporate Finance Report Summary Bryce Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Kumagai Gumi Co Ltd (1861):企業の財務・戦略的SWOT分析
    Kumagai Gumi Co Ltd (1861) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Medherant Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormo …
  • Piller Group GmbH:企業の戦略的SWOT分析
    Piller Group GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Canon USA Inc-医療機器分野:企業M&A・提携分析
    Summary Canon U.S.A. Inc (Canon), a subsidiary of Canon Inc, is a technology company that designs, develops and commercializes imaging equipment and information systems, and digital imaging solutions. The company offers products which include cameras and camcorders, lenses, flashes and binoculars, o …
  • ToolGen Inc-製薬・医療分野:企業M&A・提携分析
    Summary ToolGen Inc (ToolGen) is a genome editing company that concentrates on translating the genetic knowledge into transformative products for biomedicine and agriculture. The company creates intellectual property rights for essential tools and technologies for editing the genetic information in …
  • Cellect Biotechnology Ltd (APOP):医療機器:M&Aディール及び事業提携情報
    Summary Cellect Biotechnology Ltd (Cellect Biotechnology) formerly Cellect Biomed Ltd is a clinical stage biotechnology company which develops stem cell selection technologies for the production of stem cells based products in the field of regenerative medicine. The company’s technology platform is …
  • Sinopac Financial Holdings Company Limited
    Sinopac Financial Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopac Financial Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Amedica Corp (AMDA):製品パイプライン分析
    Summary Amedica Corp (Amedica) is a biomaterial company. It develops, manufactures and markets medical-grade silicon nitride ceramics for spinal and arthroplasty applications. The company offers interbody fusion devices, pedicle screw systems, facet fixation systems and others. Amedica also offers n …
  • Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhangzhou Pientzehuang Pharmaceutical Co Ltd (Pientzehuang), a subsidiary of Zhangzhou Jiulongjiang Construction Co Ltd, is a pharmaceutical company that manufactures and markets traditional Chinese medicines. The company develops medicines and health products, cosmetics, daily chemicals, me …
  • Suburban Propane Partners, L.P.:企業の戦略・SWOT・財務情報
    Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Steris PLC:企業の戦略・SWOT・財務分析
    Steris PLC - Strategy, SWOT and Corporate Finance Report Summary Steris PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • RRB Energy Ltd:企業の戦略的SWOT分析
    RRB Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Shenzhen Kaifa Technology Co Ltd (000021):企業の財務・戦略的SWOT分析
    Shenzhen Kaifa Technology Co Ltd (000021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆